BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kaczyńska K, Kogut E, Zając D, Jampolska M, Andrzejewski K, Sulejczak D, Lipkowski AW, Kleczkowska P. Neurotensin-based hybrid peptide's anti-inflammatory activity in murine model of a contact sensitivity response. Eur J Pharm Sci 2016;93:84-9. [PMID: 27509866 DOI: 10.1016/j.ejps.2016.08.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Ádám D, Arany J, Tóth KF, Tóth BI, Szöllősi AG, Oláh A. Opioidergic Signaling-A Neglected, Yet Potentially Important Player in Atopic Dermatitis. Int J Mol Sci 2022;23:4140. [PMID: 35456955 DOI: 10.3390/ijms23084140] [Reference Citation Analysis]
2 Fu Y, Leng C, Fan Y, Ma X, Li X, Wang X, Guo Z, Wang X, Shang R. In Vitro and In Vivo Activity of 14-O-[(4,6-Diamino-pyrimidine-2-yl) thioacetyl] Mutilin against Methicillin-Resistant Staphylococcus aureus. Molecules 2021;26:3277. [PMID: 34071703 DOI: 10.3390/molecules26113277] [Reference Citation Analysis]
3 Gein SV, Baeva TA. [Endomorphins: structure, localization, immunoregulatory activity]. Probl Endokrinol (Mosk) 2020;66:78-86. [PMID: 33351316 DOI: 10.14341/probl10364] [Reference Citation Analysis]
4 Frączek K, Ferraiolo M, Hermans E, Bujalska-Zadrozny M, Kasarello K, Erdei A, Kulik K, Kowalczyk A, Wojciechowski P, Sulejczak D, Sosnowski P, Granica S, Benyhe S, Kaczynska K, Nagraba L, Stolarczyk A, Cudnoch-Jedrzejewska A, Kleczkowska P. Novel opioid-neurotensin-based hybrid peptide with spinal long-lasting antinociceptive activity and a propensity to delay tolerance development. Acta Pharm Sin B 2020;10:1440-52. [PMID: 32963942 DOI: 10.1016/j.apsb.2020.04.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Russjan E, Andrzejewski K, Sulejczak D, Kleczkowska P, Kaczyńska K. Endomorphin-2- and Neurotensin- Based Chimeric Peptide Attenuates Airway Inflammation in Mouse Model of Nonallergic Asthma. Int J Mol Sci 2019;20:E5935. [PMID: 31779093 DOI: 10.3390/ijms20235935] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wang C, Yang C, Chen YC, Ma L, Huang K. Rational Design of Hybrid Peptides: A Novel Drug Design Approach. Curr Med Sci 2019;39:349-55. [PMID: 31209802 DOI: 10.1007/s11596-019-2042-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
7 Han HM, Ko S, Cheong MJ, Bang JK, Seo CH, Luchian T, Park Y. Myxinidin2 and myxinidin3 suppress inflammatory responses through STAT3 and MAPKs to promote wound healing. Oncotarget 2017;8:87582-97. [PMID: 29152103 DOI: 10.18632/oncotarget.20908] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
8 Kaczyńska K, Wojciechowski P, Jampolska M, Lipkowski AW, Kleczkowska P. Cardiovascular and respiratory activity of PK20, opioid and neurotensin hybrid peptide in anesthetized and awake rats. Eur J Pharmacol 2017;797:20-5. [PMID: 28089918 DOI: 10.1016/j.ejphar.2017.01.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]